Navigation Links
PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011
Date:11/28/2011

ANNAPOLIS, Md., Nov. 28, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Eric I. Richman, President and Chief Executive Officer will present at the Piper Jaffray 23rd Annual Healthcare Conference being held November 29-30, 2011. 

Mr. Richman will also be available to participate in one-on-one meetings at the conference.Event:

Piper Jaffray Healthcare ConferenceDate:

Wednesday, November 30, 2011Place:

New York Palace Hotel, Kennedy One Room, 455 Madison Ave, New York, NYTime:

12:30 pm ET About PharmAthene, Inc.PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Recombinant BChE- a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents
  • In addition, pursuant to an opinion issued September 22, 2011 from the Delaware Court of Chancery, PharmAthene is entitled to 50% of the profits over 10 years from all sales of SIGA Technologies' ST-246, and related products, a novel smallpox antiviral agent being developed by SIGA for the treatment and prevention of morbidity and mortality associated with exposure to the causative agent of smallpox (once SIGA receives the first $40 million in net profits from sales of ST-246.)

    For more information about PharmAthene, please visit www.PharmAthene.com.


    '/>"/>
    SOURCE PharmAthene, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. PharmAthene to Present at the 2011 Chemical and Biological Defense Science and Technology Conference
    2. PharmAthene to Host Third Quarter 2011 Conference Call and Webcast on Wednesday, November 9, 2011
    3. PharmAthene Submits Legal Brief in Response to SIGA Technologies Motion for Reargument
    4. PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court
    5. PharmAthene Announces $6.5 Million Registered Direct Offering
    6. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
    7. PharmAthene Provides Update on Litigation With SIGA Technologies
    8. PharmAthene Presents New Anthrax Data at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
    9. PharmAthene to Host Third Quarter 2010 Conference Call and Webcast on Thursday, November 11, 2010
    10. PharmAthene Announces Closing of $15 Million Public Offering
    11. PharmAthene Appoints Eric I. Richman President and Chief Executive Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market Size & Forecast By Type (Insource IONM, Outsource IONM), ... report to their offering. ... The global Intraoperative Neuromonitoring (IONM) market ... intraoperative neuromonitoring market is anticipated to witness significant growth in ...
    (Date:3/29/2017)... , March 29, 2017  Bodycad announced today ... Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental ... truly personalized orthopaedic restoration. Bodycad is the first ... joint reconstruction implant system. Bodycad,s ... personalized restoration of the patient,s unique anatomical features ...
    (Date:3/29/2017)... , March 29, 2017 Wound care ... promote healing of the wound. The industry mainly consists ... products for the treatment of wounds caused by mechanical, ... due to diseases such as diabetes, skin related diseases, ... Europe was the largest region in ...
    Breaking Medicine Technology:
    (Date:3/29/2017)... ... ... During the last week of March, Chad Kawa, MD of Revere Health ... local community. , Colon cancer is the second leading cause of cancer deaths ... is small, confined and easier to treat. If you are 50 or older, colonoscopies ...
    (Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced ... dealer websites for its network of more than 650 U.S.-based dealers. Rhino, a member ... including rotary and flail mowers and cutters, rear blades, post hole diggers, pasture renovators, ...
    (Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
    (Date:3/29/2017)... ... March 29, 2017 , ... ... professional squash, announced it has enlisted New York City-based sports and entertainment marketing ... develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes ...
    (Date:3/29/2017)... ... ... Full Contact K9, an Atlanta-based dog services provider, has recently teamed up ... owners in creating legally-enforceable pet trusts for their canine companions. , Therilus, a ... their new companion. Says Evan Dunbar, CEO of Full Contact K9, “When our clients ...
    Breaking Medicine News(10 mins):